Abbott Submits PMA For Absorb Bioresorbable Scaffold

The firm's FDA submission for the first-in-class bioresorbable vascular scaffold was completed in the second quarter, a spokesman said. That appears to be ahead of a prior estimate to submit by the end of 2015.

More from Archive

More from Medtech Insight